OPNT - Opiant Pharmaceuticals GAAP EPS of $0.11 beats by $0.01 revenue of $13.8M beats by $0.54M March, 15 2022 04:09 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals press release (NASDAQ:OPNT): Q4 GAAP EPS of $0.11 beats by $0.01. Revenue of $13.8M (+39.1% Y/Y) beats by $0.54M. For further details see: Opiant Pharmaceuticals GAAP EPS of $0.11 beats by $0.01, revenue of $13.8M beats by $0.54M